<unk>  is a corticosteroid that is FDA approved for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older.   Common adverse reactions include cushingoid appearance, weight increased, increased appetite, upper respiratory tract infection, cough, pollakiuria, hirsutism, central obesity, and nasopharyngitis.
Deflazacort
Toremifene
Nedocromil
Tasimelteon
Nomifensine
Plerixafor
Clebopride
Guaifenesin